AI English summary of an SEC filing — figures as filed
The company said the cyberattack impact for Q1 2024 was $0.74 per share ($0.49 in direct response costs and $0.25 in business disruption impacts), and estimated the full-year impact at $1.15 to $1.35 per share. It also said it had provided over $6 billion in advance funding and interest-free loans to care providers.
Key points
AI summaryThe company said the cyberattack impact for Q1 2024 was $0.74 per share ($0.49 in direct response costs and $0.25 in business disruption impacts), and estimated the full-year impact at $1.15 to $1.35 per share. It also said it had provided over $6 billion in advance funding and interest-free loans to care providers.
The company reported a diluted net loss per share of $(1.53) for Q1, reflecting the $7,086 million loss on the Brazil sale, which is recorded below operating income. Adjusted earnings per share were $6.91, excluding direct response costs and the Brazil sale impact but including $0.25 in business disruption impacts.
The company said revenues for Q1 2024 were $99.8 billion, up nearly $8 billion from a year earlier, and earnings from operations were $7.9 billion. Adjusted earnings from operations were $8.5 billion, and earnings from operations included $872 million in unfavorable cyberattack effects.
The company said cash flows from operations for Q1 were $1.1 billion, and were affected by about $3 billion from its cyberattack response actions and by the timing of public sector cash receipts. It also said it returned $4.8 billion to shareholders through dividends and share repurchases in the quarter.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Change Healthcare Cyberattack Impacts and Full-Year Estimates
The company said the cyberattack impact for Q1 2024 was $0.74 per share ($0.49 in direct response costs and $0.25 in business disruption impacts), and estimated the full-year impact at $1.15 to $1.35 per share. It also said it had provided over $6 billion in advance funding and interest-free loans to care providers.
Source · Based on the filing body and exhibits
Q1 Net Loss, Brazil Sale Impact and Adjusted EPS
The company reported a diluted net loss per share of $(1.53) for Q1, reflecting the $7,086 million loss on the Brazil sale, which is recorded below operating income. Adjusted earnings per share were $6.91, excluding direct response costs and the Brazil sale impact but including $0.25 in business disruption impacts.
Source · Based on the filing body and exhibits
Q1 Revenue and Earnings from Operations
The company said revenues for Q1 2024 were $99.8 billion, up nearly $8 billion from a year earlier, and earnings from operations were $7.9 billion. Adjusted earnings from operations were $8.5 billion, and earnings from operations included $872 million in unfavorable cyberattack effects.
Source · Based on the filing body and exhibits
Operating Cash Flow and Shareholder Returns
The company said cash flows from operations for Q1 were $1.1 billion, and were affected by about $3 billion from its cyberattack response actions and by the timing of public sector cash receipts. It also said it returned $4.8 billion to shareholders through dividends and share repurchases in the quarter.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…